Van Thanh Ly, NP
Nurse Practitioner · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Van Thanh Ly’s office to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$214,739
Pharmacies billed $214,739 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (30 of 3,691) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
3,292 generic and 374 brand-name prescriptions · $214,739 in drug cost · 283 antibiotic prescriptions to 245 people · 32 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 46 | $31,247 | $679 |
| Rybelsus | 15 | $21,408 | $1,427 |
| Jardiance | 19 | $20,930 | $1,102 |
| Farxiga | 21 | $15,215 | $725 |
| Januvia | 11 | $11,307 | $1,028 |
See all 71 drugs
| Trelegy Ellipta | 46 | $31,247 | $679 |
| Rybelsus | 15 | $21,408 | $1,427 |
| Jardiance | 19 | $20,930 | $1,102 |
| Farxiga | 21 | $15,215 | $725 |
| Januvia | 11 | $11,307 | $1,028 |
| Vascepa | 19 | $9,254 | $487 |
| Icosapent Ethyl | 16 | $5,612 | $351 |
| Albuterol Sulfate Hfa | 169 | $5,209 | $31 |
| Atorvastatin | 187 | $2,673 | $14 |
| Losartan | 239 | $2,515 | $11 |
| Metoprolol | 124 | $2,017 | $16 |
| Amlodipine Besylate | 210 | $1,501 | $7 |
| Gabapentin | 100 | $1,473 | $15 |
| Ventolin Hfa | 24 | $1,331 | $55 |
| Celecoxib | 21 | $1,187 | $57 |
| Megestrol Acetate | 18 | $1,057 | $59 |
| Omeprazole | 89 | $1,021 | $11 |
| Rosuvastatin | 67 | $829 | $12 |
| Tamsulosin | 57 | $816 | $14 |
| Metformin | 93 | $796 | $9 |
| Omega-3 Acid Ethyl Esters | 13 | $790 | $61 |
| Fenofibrate | 34 | $745 | $22 |
| Triamcinolone Acetonide | 73 | $732 | $10 |
| Quetiapine | 18 | $726 | $40 |
| Fluticasone Propionate | 76 | $696 | $9 |
| Diclofenac | 37 | $687 | $19 |
| Azelastine | 44 | $622 | $14 |
| Ketoconazole | 41 | $613 | $15 |
| Simvastatin | 52 | $588 | $11 |
| Montelukast | 49 | $578 | $12 |
| Neomycin-Polymyxin-Hydrocort | 12 | $528 | $44 |
| Azithromycin | 134 | $489 | $4 |
| Hydralazine | 57 | $419 | $7 |
| Levothyroxine | 26 | $409 | $16 |
| Metoprolol | 31 | $390 | $13 |
| Nitrofurantoin Mono-Macro | 28 | $384 | $14 |
| Pantoprazole | 37 | $383 | $10 |
| Atenolol | 21 | $378 | $18 |
| Lisinopril | 43 | $370 | $9 |
| Mirtazapine | 11 | $324 | $29 |
| Finasteride | 23 | $311 | $14 |
| Hydrocortisone | 32 | $272 | $9 |
| Glipizide | 22 | $268 | $12 |
| Allopurinol | 26 | $262 | $10 |
| Donepezil | 11 | $223 | $20 |
| Ofloxacin | 11 | $216 | $20 |
| Benzonatate | 18 | $213 | $12 |
| Amoxicillin-Clavulanate Potass | 33 | $193 | $6 |
| Ibuprofen | 46 | $190 | $4 |
| Baclofen | 55 | $188 | $3 |
| Clopidogrel | 20 | $182 | $9 |
| Trazodone | 24 | $179 | $7 |
| Cephalexin | 31 | $170 | $5 |
| Losartan-Hydrochlorothiazide | 20 | $170 | $8 |
| Zolpidem | 36 | $151 | $4 |
| Furosemide | 28 | $150 | $5 |
| Oxybutynin Chloride | 17 | $128 | $8 |
| Promethazine-Dm | 12 | $128 | $11 |
| Loperamide | 14 | $128 | $9 |
| Meclizine | 21 | $123 | $6 |
| Pregabalin | 16 | $109 | $7 |
| Pravastatin | 12 | $109 | $9 |
| Hydroxyzine | 22 | $105 | $5 |
| Carvedilol | 22 | $100 | $5 |
| Metformin Hcl Er | 13 | $96 | $7 |
| Diphenoxylate-Atropine | 13 | $91 | $7 |
| Lorazepam | 24 | $86 | $4 |
| Amoxicillin | 33 | $80 | $2 |
| Prednisone | 40 | $76 | $2 |
| Tramadol | 21 | $71 | $3 |
| Chlorhexidine Gluconate | 13 | $60 | $5 |
Year by year
| 2024 | 3,691 | 726 | 1% (30) | 10% | $214,739 |
| 2023 | 2,767 | 526 | 1% (15) | None | $263,160 |
| 2022 | 910 | 329 | None | None | $43,094 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 60 drugs
| Trelegy Ellipta | 53 | $36,684 | $692 |
| Rybelsus | 14 | $27,982 | $1,999 |
| Eliquis | 16 | $18,018 | $1,126 |
| Vascepa | 15 | $11,890 | $793 |
| Ventolin Hfa | 67 | $4,609 | $69 |
| Atorvastatin | 124 | $3,617 | $29 |
| Losartan | 147 | $3,391 | $23 |
| Albuterol Sulfate Hfa | 77 | $3,370 | $44 |
| Basaglar Kwikpen U-100 | 12 | $3,158 | $263 |
| Celecoxib | 28 | $2,692 | $96 |
| Amlodipine Besylate | 112 | $2,685 | $24 |
| Diclofenac | 62 | $2,093 | $34 |
| Gabapentin | 77 | $2,077 | $27 |
| Tamsulosin | 48 | $1,901 | $40 |
| Megestrol Acetate | 17 | $1,672 | $98 |
| Fenofibrate | 25 | $1,668 | $67 |
| Metoprolol | 64 | $1,664 | $26 |
| Simvastatin | 46 | $1,377 | $30 |
| Rosuvastatin | 31 | $1,197 | $39 |
| Metformin | 63 | $1,181 | $19 |
| Omega-3 Acid Ethyl Esters | 15 | $1,156 | $77 |
| Triamcinolone Acetonide | 47 | $1,088 | $23 |
| Fluticasone Propionate | 77 | $1,054 | $14 |
| Omeprazole | 50 | $1,048 | $21 |
| Pantoprazole | 42 | $930 | $22 |
| Azelastine | 30 | $927 | $31 |
| Azithromycin | 117 | $918 | $8 |
| Metoprolol | 38 | $847 | $22 |
| Memantine | 11 | $836 | $76 |
| Baclofen | 64 | $832 | $13 |
| Neomycin-Polymyxin-Hydrocort | 14 | $824 | $59 |
| Glipizide | 32 | $786 | $25 |
| Montelukast | 27 | $785 | $29 |
| Levothyroxine | 25 | $712 | $28 |
| Finasteride | 17 | $658 | $39 |
| Ipratropium | 20 | $648 | $32 |
| Hydrocortisone | 30 | $645 | $22 |
| Hydralazine | 27 | $634 | $23 |
| Clopidogrel | 19 | $615 | $32 |
| Carvedilol | 20 | $573 | $29 |
| Oseltamivir Phosphate | 15 | $559 | $37 |
| Ibuprofen | 50 | $495 | $10 |
| Ketoconazole | 17 | $490 | $29 |
| Trazodone | 28 | $464 | $17 |
| Lisinopril | 19 | $454 | $24 |
| Donepezil | 11 | $381 | $35 |
| Atenolol | 19 | $352 | $19 |
| Glipizide Er | 12 | $334 | $28 |
| Ofloxacin | 11 | $310 | $28 |
| Allopurinol | 13 | $296 | $23 |
| Cephalexin | 29 | $284 | $10 |
| Nitrofurantoin Mono-Macro | 17 | $271 | $16 |
| Amoxicillin | 54 | $267 | $5 |
| Mupirocin | 18 | $227 | $13 |
| Loperamide | 11 | $213 | $19 |
| Furosemide | 30 | $185 | $6 |
| Meclizine | 12 | $145 | $12 |
| Cilostazol | 11 | $145 | $13 |
| Chlorhexidine Gluconate | 20 | $128 | $6 |
| Prednisone | 37 | $105 | $3 |
2022: 24 drugs
| Celecoxib | 13 | $1,802 | $139 |
| Albuterol Sulfate Hfa | 29 | $1,272 | $44 |
| Fluticasone Propionate | 44 | $626 | $14 |
| Azithromycin | 77 | $611 | $8 |
| Oseltamivir Phosphate | 12 | $578 | $48 |
| Ipratropium | 14 | $574 | $41 |
| Baclofen | 22 | $545 | $25 |
| Omeprazole | 27 | $524 | $19 |
| Diclofenac | 21 | $507 | $24 |
| Triamcinolone Acetonide | 21 | $481 | $23 |
| Tamsulosin | 17 | $472 | $28 |
| Losartan | 33 | $470 | $14 |
| Azelastine | 11 | $420 | $38 |
| Atorvastatin | 22 | $416 | $19 |
| Amlodipine Besylate | 24 | $250 | $10 |
| Gabapentin | 18 | $237 | $13 |
| Hydrocortisone | 12 | $217 | $18 |
| Ciprofloxacin | 17 | $156 | $9 |
| Ibuprofen | 14 | $147 | $11 |
| Metformin | 11 | $144 | $13 |
| Amoxicillin | 24 | $142 | $6 |
| Cephalexin | 16 | $122 | $8 |
| Furosemide | 11 | $51 | $5 |
| Prednisone | 16 | $50 | $3 |
Money from drug and device companies
$725 in 2025
| 2025 | 9 | 33 | None | $725 |
| 2024 | 3 | 18 | None | $243 |
| 2023 | 2 | 2 | None | $54 |
| 2022 | 2 | 4 | None | $184 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $236 | 11 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $216 | 10 payments
|
| Kowa Pharmaceuticals America | Zoryve | $69 | 3 payments
|
| Sumitomo Pharma America | Gemtesa | $55 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $50 | 2 payments
|
| Novo Nordisk | Rybelsus | $31 | 1 payment
|
See all 33 published payments
| GlaxoSmithKline | Meals · 2025-12-16 | Trelegy Ellipta | $28 |
| Gilead Sciences | Meals · 2025-11-14 | None | $30 |
| GlaxoSmithKline | Meals · 2025-10-28 | Trelegy Ellipta | $22 |
| Kowa Pharmaceuticals America | Meals · 2025-10-17 | Zoryve | $20 |
| Novo Nordisk | Meals · 2025-10-16 | Rybelsus | $31 |
| Lilly USA | Meals · 2025-10-14 | Mounjaro | $20 |
| Sumitomo Pharma America | Meals · 2025-10-10 | Gemtesa | $18 |
| GlaxoSmithKline | Meals · 2025-09-17 | Trelegy Ellipta | $33 |
| Sumitomo Pharma America | Meals · 2025-09-11 | Gemtesa | $23 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-11 | Xifaxan | $18 |
| Kowa Pharmaceuticals America | Meals · 2025-09-11 | Zoryve | $25 |
| GlaxoSmithKline | Meals · 2025-09-04 | Trelegy Ellipta | $33 |
| Sumitomo Pharma America | Meals · 2025-08-27 | Gemtesa | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-14 | Caplyta | $33 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-30 | Caplyta | $25 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-23 | Caplyta | $19 |
| GlaxoSmithKline | Meals · 2025-07-07 | Trelegy Ellipta | $11 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-18 | Caplyta | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-04 | Caplyta | $22 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-04 | Caplyta | $3 |
| Kowa Pharmaceuticals America | Meals · 2025-05-30 | Zoryve | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-28 | Kerendia | $23 |
| GlaxoSmithKline | Meals · 2025-05-19 | Trelegy Ellipta | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-15 | Caplyta | $21 |
| GlaxoSmithKline | Meals · 2025-05-01 | Trelegy Ellipta | $19 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-21 | Caplyta | $26 |
| GlaxoSmithKline | Meals · 2025-04-17 | Trelegy Ellipta | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-09 | Kerendia | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-02 | Caplyta | $33 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-12 | Caplyta | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-12 | Caplyta | $6 |
| GlaxoSmithKline | Meals · 2025-01-21 | Trelegy Ellipta | $29 |
| GlaxoSmithKline | Meals · 2025-01-17 | Trelegy Ellipta | $28 |
See earlier years (2024, 2023, 2022)
2024: $243
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $150 | 14 payments
|
| Pfizer | Paxlovid | $71 | 3 payments
|
| Vivus | Pancreaze | $22 | 1 payment
|
2023: $54
| GlaxoSmithKline | Trelegy Ellipta | $29 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $26 | 1 payment
|
2022: $184
| Gilead Sciences | Vemlidy | $125 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $59 | 3 payments
|
Professional record
- NPI
- 1790426781
- Licence
- CA 95020564
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 8721 Church St, Gilroy, CA, 95020
- NPI first listed
- 2022-04-05
- NPI last updated
- 2022-09-06
- NPI record certified
- 2022-09-06
This is when the NPI record was last certified, not a medical board exam.